Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more

TSX:RVX - Post Discussion

Resverlogix Corp > Globe Newswire
View:
Post by G1945V on Jan 18, 2021 7:38am

Globe Newswire

Resverlogix Announces Update Webcast and Conference Call

 


CALGARY, Alberta, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today announced that on January 28th, 2021 at 10:00 am MT, it will be hosting a webcast and conference call for the purpose of updating stakeholders regarding three key areas:

  • Closing details of the previously announced private placement by Sheikh Abdulgader Aboud Baeshen, President and CEO of Baeshen Trade, Abdulgader Baeshen Co.,
  • BETonMACE2 design upgrades and partnering options, and
  • COVID-19 trial update and apabetalone’s strong antiviral effect

For those wishing to join the January 28th event, it is highly recommended to access the webcast over the Internet using the following LINK.

If dialing in by phone, dial 1-800-319-4610 (within Canada / USA) or +1-403-351-0324 (International Toll). Callers should dial-in at least 10 min prior to the scheduled start time.

G1945V

Comment by QualityTest on Jan 18, 2021 7:49am
We are so screwed. I'm guessing no BP is very interested in partnering.
Comment by QualityTest on Jan 18, 2021 8:00am
Why the hell did ORI convert???? They must have seen something but the fact that we had to get this PP screams that no BP wants to do business ATM.
Comment by QualityTest on Jan 18, 2021 9:32am
a wild guess on my part regarding partnering updates is we may hear that they have secured funding from insiders for option 3 from Sept presentation (hello dilution) and can proceed quickly with that or we can wait for Covid to settle down and attempt to proceed with option 1 (BP). not feeling optimistic whatsoever about this update. Hopefully the reason to delay it 10 days is the Covid data that ...more  
Comment by narmac on Jan 18, 2021 5:30pm
aaacccchhhh,,iit should not be a surprise,,,,option B or C would fit right in with DMcC business prowess,,,,,,,,,wait a year with his thumb in his bum and be left with the paper bag on fire on his doorstep, I think an internal power struggle from the major insiders are the reason no deal is done,,,and we have been in limbo for the past year+. Just an opinion based on not being able to access tea ...more  
Comment by G1945V on Feb 01, 2021 2:02pm
As much being said about a deal in place with a Big Pharma, would Don have stated it this way,-- that the purpose of the updating is "BETonMACE2 design upgrades and partnering options". If there is already a set partnership, there would be no need to updating the shareholders with "partnering options" when there would only be one out of the three, namely Option No1 ...more  
Comment by narmac on Feb 01, 2021 2:33pm
,,gv,,my guess is,,,, no partner,,,still talking,,,,and talking,,and more talking planned,,,,,basic timeline going to be given on BoM2,,,,,,,focus will try to be put on covid data/trial etc to get away from the partnership failure,,,, ,,nothing material,,,,,,I am not going to even log in to listen to all the Calgary excitiement incase I mt my bowels into my shorts,,,, this company is pitiable ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities